E2F1 and breast carcinoma: Although E2F1 has been well supported to be involved in chemotherapeutic drug resistance, the functional interplay between the E2F1 gene and chemotherapeutic drugs has not yet been investigated in breast cancer, to the best of the authors' knowledge.